Ra Capital Management, Director: Mineralys Therapeutics MLYS Buy · Filed 03/31

Trade details

Type: Insider buy
Amount: $1,408,528
Shares · price: 58,300 sh · $24.16 a share
Held after: 5,825,521 sh
Stock: Mineralys Therapeutics MLYS
Person: Ra Capital ManagementDirector
Trade date: 26/03/30
Filed: 26/03/31
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 5 insiders
Holding change: +1.0%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 02/28~04/29

Ra Capital Management's recent trades

Ra Capital ManagementDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$275.3K
31,000 sh
$275.3K
Filed 06/29
Traded 06/25
Ra Capital ManagementDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
Ra Capital Management10% Owner
SellWerewolf Therapeutics
Sell
Werewolf Therapeutics
HOWL
$136.2K
389,216 sh
$136.2K
Filed 06/22
Traded 06/17
Ra Capital Management10% Owner
SellWerewolf Therapeutics
Sell
Werewolf Therapeutics
HOWL
$9,693
27,695 sh
$9,693
Filed 06/22
Traded 06/17
Ra Capital Management10% Owner
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.5M
61,523 sh
$1.5M
Filed 06/17
Traded 06/16